Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
Donfrancesco A, Jenkner A, Castellano A, Ilari I, Milano GM, De Sio L, Cozza R, Fidani P, Deb G, De Laurentis C, Inserra A, Dominici C. Donfrancesco A, et al. Acta Paediatr Suppl. 2004 May;93(445):6-11. doi: 10.1111/j.1651-2227.2004.tb03048.x. Acta Paediatr Suppl. 2004. PMID: 15176712 Clinical Trial.
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
Milano GM, Cozza R, Ilari I, De Sio L, Boldrini R, Jenkner A, De Ioris M, Inserra A, Dominici C, Donfrancesco A. Milano GM, et al. Among authors: donfrancesco a. Cancer. 2006 Apr 15;106(8):1838-45. doi: 10.1002/cncr.21780. Cancer. 2006. PMID: 16532434 Free article. Clinical Trial.
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R, Milano GM, Garrè ML, Donfrancesco A. Fidani P, et al. Among authors: donfrancesco a. J Neurooncol. 2009 Apr;92(2):177-83. doi: 10.1007/s11060-008-9750-y. Epub 2008 Nov 29. J Neurooncol. 2009. PMID: 19048188 Clinical Trial.
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
De Ioris MA, Castellano A, Ilari I, Garganese MC, Natali G, Inserra A, De Vito R, Ravà L, De Pasquale MD, Locatelli F, Donfrancesco A, Jenkner A. De Ioris MA, et al. Among authors: donfrancesco a. Eur J Cancer. 2011 Mar;47(4):572-8. doi: 10.1016/j.ejca.2010.10.023. Epub 2010 Nov 26. Eur J Cancer. 2011. PMID: 21112775
120 results